Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers
- PMID: 23634247
- PMCID: PMC3633979
Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers
Abstract
Background: Emerging evidence has suggested that Notch signaling pathway may be involved in the development, progression and metastasis of prostate cancer (PCa). In the present study, we investigated the expression levels of Jagged-1 and Notch-1 in human prostate tumors and their associations with PCa progression and metastasis.
Methods: Immunohistochemistry (IHC) for Jagged-1 and Notch-1 was performed on tissue microarray (TMA) slides containing 286 formalin-fixed and paraffin-embedded (FFPE) tissue specimens with various prostatic pathologies, including benign changes, high grade prostatic intraepithelial neoplasia (HGPIN), low- and high-grade PCas as well as metastatic PCa.
Results: Cytoplasmic and membranous IHC scores for Jagged-1 in both metastatic PCa and high grade PCa were significantly higher than those in low grade PCa and in benign prostatic tissues. Similarly, cytoplasmic IHC scores of Notch-1 in both metastatic PCa and high grade PCa were significantly elevated compared with those observed in low grade PCa and in benign prostatic tissues. A statistically significant correlation was identified between the expression of Jagged-1 and Notch-1 in human prostatic tissues. Furthermore, significantly more highly expressed Jagged-1 in membrane was observed in Caucasian patients with high-grade or metastatic PCa (vs. African Americans) and in PCa patients with positive surgical margins (vs. negative surgical margins).
Conclusion: Our results provide strong evidence that up-regulation of Jagged1-Notch1 signaling plays a role in PCa progression and metastasis and suggest that Jagged-1 and Notch-1 may be useful markers in distinguishing indolent and aggressive PCas.
Keywords: Jagged-1; Notch-1; Prostate cancer (PCa); cancer metastasis; immunohistochemistry (IHC); tissue microarray (TMA).
Figures



Similar articles
-
Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.Pathol Oncol Res. 2016 Jan;22(1):87-94. doi: 10.1007/s12253-015-9983-y. Epub 2015 Sep 5. Pathol Oncol Res. 2016. PMID: 26341090
-
JAGGED1 expression is associated with prostate cancer metastasis and recurrence.Cancer Res. 2004 Oct 1;64(19):6854-7. doi: 10.1158/0008-5472.CAN-04-2500. Cancer Res. 2004. PMID: 15466172
-
Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.Jpn J Clin Oncol. 2004 Jul;34(7):414-9. doi: 10.1093/jjco/hyh073. Jpn J Clin Oncol. 2004. PMID: 15342669
-
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.Am J Surg Pathol. 2014 Aug;38(8):e6-e19. doi: 10.1097/PAS.0000000000000238. Am J Surg Pathol. 2014. PMID: 25029122
-
Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy.Oncol Lett. 2019 Sep;18(3):2743-2755. doi: 10.3892/ol.2019.10653. Epub 2019 Jul 22. Oncol Lett. 2019. PMID: 31452752 Free PMC article. Review.
Cited by
-
Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer.Oncotarget. 2017 Aug 9;8(58):97703-97726. doi: 10.18632/oncotarget.20097. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228645 Free PMC article.
-
Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.J Clin Invest. 2016 Jul 1;126(7):2626-41. doi: 10.1172/JCI84637. Epub 2016 Jun 13. J Clin Invest. 2016. PMID: 27294523 Free PMC article.
-
Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance.Cancer Drug Resist. 2022 Oct 18;5(4):939-953. doi: 10.20517/cdr.2022.46. eCollection 2022. Cancer Drug Resist. 2022. PMID: 36627893 Free PMC article. Review.
-
Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks.Sci Rep. 2022 Jun 16;12(1):10073. doi: 10.1038/s41598-022-13279-x. Sci Rep. 2022. PMID: 35710817 Free PMC article.
-
Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance.Cancers (Basel). 2021 Jun 4;13(11):2795. doi: 10.3390/cancers13112795. Cancers (Basel). 2021. PMID: 34199763 Free PMC article. Review.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Miele L. Notching signaling. Clin Cancer Res. 2006;12:1074–1079. - PubMed
-
- Miele L, Miao H, Nickoloff BJ. NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets. 2006;6:313–323. - PubMed
-
- Shih IeM, Wang TL. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res. 2007;5:1879–1882. - PubMed
-
- Sade H, Krishna S, Sarin A. he anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J Biol Chem. 2004;279:2937–2944. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources